Document Detail


Positron emission tomography in urologic oncology.
MedLine Citation:
PMID:  12228759     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Positron emission tomography (PET) is an emerging imaging modality that is being investigated for use in urologic oncology. PET scanning using the radioactive glucose analog FDG has proven to be a highly accurate imaging test for diagnosing and staging a variety of non-urologic cancer types. This review was performed to determine the role of PET imaging in genitourinary malignancies. METHODS: A review of the literature focusing on PET and urologic oncology was performed. The role of PET imaging was reviewed in prostate, bladder, renal, and testicular cancer. RESULTS: In testicular cancer, PET has a higher diagnostic accuracy than computed tomography (CT) for both staging and re-staging and should be the test of choice for the assessment of a CT-visualized residual mass following chemotherapy. In prostate, renal, and bladder cancer, the current role of PET is still being defined, but it has a high positive predictive value and can be used for problem solving in patients with indeterminate findings on conventional imaging. Its role in the diagnosis and staging of prostate cancer is hampered by the generally low glycolytic rate of most prostate tumors and their metastases. It has shown promise for staging and re-staging patients with advanced-stage disease and aggressive tumors suspected by a high tumor grade and high prostate-specific antigen velocity. PET has also demonstrated success when applied to renal cell carcinoma in classifying indeterminate renal masses as well as residual renal fossa masses following nephrectomy, gauging response to therapy, and staging and re-staging patients with a known diagnosis of renal cell carcinoma. CONCLUSIONS: PET imaging has demonstrated great potential in certain applications, but further investigations are necessary to determine its eventual place as an imaging modality in genitourinary malignancies.
Authors:
Oleg Shvarts; Ken-ryu Han; Marc Seltzer; Allan J Pantuck; Arie S Belldegrun
Related Documents :
20453649 - Initial evaluation of the nonsmall cell lung cancer patient: diagnosis and staging.
17098649 - Detection, staging and surveillance in renal cell carcinoma.
19156409 - Diagnostic accuracy of contrast-enhanced fdg-pet/ct in primary staging of cutaneous mal...
15788619 - Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative ...
17299649 - Improved non-invasive t-staging in non-small cell lung cancer by integrated 18f-fdg pet...
2288659 - Radiology in the diagnosis and staging of renal cell carcinoma.
3203039 - Assessment of the thickness of the right ventricular free wall by magnetic resonance im...
22538629 - Model-based iterative reconstruction technique for radiation dose reduction in chest ct...
17078909 - Imaging and quantifying valvular heart disease using magnetic resonance techniques.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cancer control : journal of the Moffitt Cancer Center     Volume:  9     ISSN:  1073-2748     ISO Abbreviation:  Cancer Control     Publication Date:    2002 Jul-Aug
Date Detail:
Created Date:  2002-09-13     Completed Date:  2002-10-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9438457     Medline TA:  Cancer Control     Country:  United States    
Other Details:
Languages:  eng     Pagination:  335-42     Citation Subset:  IM    
Affiliation:
Department of Urology, University of California Los Angeles School of Medicine, Los Angeles, Calif 90095, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Kidney Neoplasms / radionuclide imaging*
Male
Prostatic Neoplasms / radionuclide imaging*
Radioactive Tracers
Testicular Neoplasms / radionuclide imaging*
Tomography, Emission-Computed* / trends
Urinary Bladder Neoplasms / radionuclide imaging*
Chemical
Reg. No./Substance:
0/Radioactive Tracers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation and management of adrenal masses.
Next Document:  Redox signal transduction: reductive reasoning.